Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ 12940 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

According to our (Global Info Research) latest study, the global B-Cell Non-Hodgkin's Lymphoma Drug market size was valued at USD 8119.4 million in 2023 and is forecast to a readjusted size of USD 12940 million by 2030 with a CAGR of 6.9% during review period.

USD3480.00

Add To Cart

Add To Cart

Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

USD3480.00

Add To Cart

Add To Cart

industry 18 Feb 2024

industry Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ 12940 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2024

industry Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

According to our (Global Info Research) latest study, the global B-Cell Non-Hodgkin's Lymphoma Drug market size was valued at USD 8119.4 million in 2023 and is forecast to a readjusted size of USD 12940 million by 2030 with a CAGR of 6.9% during review period.

USD3480.00

addToCart

Add To Cart

industry 25 Feb 2023

industry Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2023

industry Pharma & Healthcare

new_biaoQian B-Cell Non-Hodgkin's Lymphoma Drug

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

USD3480.00

addToCart

Add To Cart